semaglutide – The Milli Chronicle

Saturday, April 4, 2026

Latest:

Gulf tensions ripple into India’s farms as fertiliser fears grip Punjab growers
Bangkok’s park aerobics draw Gen Z crowds as social media fuels fitness trend
India’s pre-wedding boom fuels demand for weight-loss injections despite regulatory concerns
Brazil scientists turn to wild coffee genes to safeguard arabica from climate stress
Sahel armies linked to higher civilian death tolls than jihadists, data indicates

Factual Version of a Story

NewsDesk MC April 4, 2026 arranged marriages, bariatric care, clinics, cosmetic use, drug pricing, drug regulation, Eli Lilly, generics, healthcare market, india, India healthcare, Lancet study, lifestyle medicine, metabolic health, Mounjaro, Novo Nordisk, obesity, pharmaceuticals, pre-wedding trends, semaglutide, social pressure, Wegovy, weight loss drugs, wellness industry

India’s pre-wedding boom fuels demand for weight-loss injections despite regulatory concerns

“We understand the curiosity, but this cannot be a quick fix,” said Dr. Swati Pradhan, highlighting concerns over misuse of

Featured News World

NewsDesk MC January 5, 2026 chronic obesity treatment, FDA approved weight loss pill, global pharma industry, healthcare accessibility, medical weight loss, metabolic health, needle free treatment, Novo Nordisk, obesity care, obesity treatment, oral weight loss medication, patient centered care, pharmaceutical innovation, self pay patients, semaglutide, telehealth pharmacy, US healthcare market, Wegovy pill, weight loss drug, weight management

Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill

The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United